{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:24:52Z","timestamp":1776399892515,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1038\/nm0596-574","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:30:57Z","timestamp":1092879057000},"page":"574-577","source":"Crossref","is-referenced-by-count":754,"title":["Involvement of the CD95 (APO\u20131\/Fas) receptor\/ligand system in drug\u2013induced apoptosis in leukemia cells"],"prefix":"10.1038","volume":"2","author":[{"given":"Claudia","family":"Friesen","sequence":"first","affiliation":[]},{"given":"Ingrid","family":"Herr","sequence":"additional","affiliation":[]},{"given":"Peter H.","family":"Krammer","sequence":"additional","affiliation":[]},{"given":"Klaus-Michael","family":"Debatin","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0596574_CR1","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/0006-2952(90)90733-2","volume":"40","author":"MA Barry","year":"1990","unstructured":"Barry, M.A., Behnke, C.A. & Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40, 2353\u20132362 (1990).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm0596574_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1098\/rstb.1994.0112","volume":"345","author":"JA Hickman","year":"1994","unstructured":"Hickman, J.A. et al. Apoptosis and cancer chemotherapy. Philos. Trans. R. Soc. Land. B. Biol. Sci. 345 (1313) 319\u2013325 (1994).","journal-title":"Philos. Trans. R. Soc. Land. B. Biol. Sci."},{"key":"BFnm0596574_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.2787530","volume":"245","author":"BC Trauth","year":"1989","unstructured":"Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301\u2013305 (1989).","journal-title":"Science"},{"key":"BFnm0596574_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0140-6736(90)90735-N","volume":"335","author":"K-M Debatin","year":"1990","unstructured":"Debatin, K.-M., Goldman, C.K., Bamford, R., Waldmann, T.A. & Krammer, P.M. Monoclonal antibody-mediated apoptosis in adult T cell leukemia. Lancet 335, 497\u2013500 (1990).","journal-title":"Lancet"},{"key":"BFnm0596574_CR5","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1182\/blood.V81.11.2972.2972","volume":"81","author":"K-M Debatin","year":"1993","unstructured":"Debatin, K.-M., Goldman, C.K., Waldmann, T.A. & Krammer, P.H. APO-1 induced apoptosis of leukemia cells from patients with adult T cell leukemia. Blood 81, 2972\u20132977 (1993).","journal-title":"Blood"},{"key":"BFnm0596574_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-065X.1994.tb00889.x","volume":"142","author":"PH Krammer","year":"1994","unstructured":"Krammer, P.H. et al. The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142, 175\u2013191 (1994).","journal-title":"Immunol. Rev."},{"key":"BFnm0596574_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/373438a0","volume":"373","author":"J Dhein","year":"1995","unstructured":"Dhein, J., Walczak, H., B\u00e4umler, C., Debatin, K.M. & Krammer, P.H. Autocrine T cell suicide mediated by APO-1 (Fas\/CD95). Nature 373, 438\u2013441 (1995).","journal-title":"Nature"},{"key":"BFnm0596574_CR8","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","volume":"267","author":"A Oehm","year":"1992","unstructured":"Oehm, A. et al. Purification and molecular cloning of the APO-1 surface antigen, a member of the TNF\/NGF receptor superfamily. J. Biol. Chem. 267, 10709\u201310715 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnm0596574_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","volume":"66","author":"N Itoh","year":"1991","unstructured":"Itoh, N. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233\u2013243 (1991).","journal-title":"Cell"},{"key":"BFnm0596574_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/intimm\/5.6.625","volume":"5","author":"C Klas","year":"1993","unstructured":"Klas, C., Debatin, K.M., Jonker, R.R. & Krammer, P.H. Activation interferes with the apoptotic pathway in mature human T cells. Int. Immunol. 5, 625\u2013630 (1993).","journal-title":"Int. Immunol."},{"key":"BFnm0596574_CR11","unstructured":"Kischkel, F.C. et al. Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins (CAP) form a death-inducing signalling complex (DISC) with the receptor. EMBO J. (in the press)."},{"key":"BFnm0596574_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda, T., Takahashi, S., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169\u20131178 (1993).","journal-title":"Cell"},{"key":"BFnm0596574_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/j.1460-2075.1995.tb07096.x","volume":"14","author":"M Tanaka","year":"1995","unstructured":"Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129\u20131135 (1995).","journal-title":"EMBO J."},{"key":"BFnm0596574_CR14","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/eji.1830250828","volume":"25","author":"SM Mariani","year":"1995","unstructured":"Mariani, S.M., Matiba, B., Baumler, C. & Krammer, P.H. Regulation of cell surface APO-1\/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303\u20132307 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnm0596574_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF00735923","volume":"32","author":"C Muller","year":"1993","unstructured":"Muller, C. et al. Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: Comparison of bolus administration and continuous infusion. Cancer Chemother. Pharmacol. 32, 379\u2013384 (1993).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnm0596574_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00685876","volume":"32","author":"BJ Cusack","year":"1993","unstructured":"Cusack, B.J., Young, S.P., Driskell, J. & Olson, R.D. Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit. Cancer. Chemother. Pharmacol. 32, 53\u201358 (1993).","journal-title":"Cancer. Chemother. Pharmacol."},{"key":"BFnm0596574_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0006-2952(93)90512-U","volume":"46","author":"A Skladanowski","year":"1993","unstructured":"Skladanowski, A. & Konopa, J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem. Pharmacol. 46, 375\u2013382 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm0596574_CR18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/0006-2952(92)90697-H","volume":"43","author":"NS Thakkar","year":"1992","unstructured":"Thakkar, N.S. & Potten, C.S. Abrogation of adriamycin toxicity in vivo by cy-cloheximide. Biochem. Pharmacol. 43, 1683\u20131691 (1992).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm0596574_CR19","first-page":"815","volume":"9","author":"K-M Debatin","year":"1995","unstructured":"Debatin, K.-M. & Krammer, P.H. Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent antiapoptotic program. Leukemia 9 (5), 815\u2013820 (1995).","journal-title":"Leukemia"},{"key":"BFnm0596574_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0092-8674(95)90429-8","volume":"82","author":"R Bose","year":"1995","unstructured":"Bose, R. et al. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signal. Cell 82, 405\u2013414 (1995).","journal-title":"Cell"},{"key":"BFnm0596574_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.180.4.1547","volume":"177","author":"MG Cifone","year":"1994","unstructured":"Cifone, M.G. et al. Apoptotic signaling through CD95 (Fas\/APO-1) activates an acidic sphingomyelinase. Exp. Med. 177, 1547\u20131552 (1994)","journal-title":"Exp. Med."},{"key":"BFnm0596574_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/376037a0","volume":"376","author":"DW Nicholson","year":"1995","unstructured":"Nicholson, D.W. et al. Identification and inhibition of ICE\/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37\u201343 (1995).","journal-title":"Nature"},{"key":"BFnm0596574_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immun. Methods 139, 271\u2013279 (1991).","journal-title":"J. Immun. Methods"},{"key":"BFnm0596574_CR24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood.V83.5.1268.1268","volume":"83","author":"M Carbonari","year":"1994","unstructured":"Carbonari, M. et al. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus-infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83, 1268\u20131277 (1994).","journal-title":"Blood"},{"key":"BFnm0596574_CR25","unstructured":"Herr, I. et al. Monitoring of CD95 (APO-1\/FAS) ligand expression in human T cells by quantitative RT-PCR. Cell Death Diff. (in the press)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0596-574","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0596-574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0596-574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:38:43Z","timestamp":1684449523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0596-574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BFnm0596574"],"URL":"https:\/\/doi.org\/10.1038\/nm0596-574","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}